Insulin resistance in the vasculature
Kieren J Mather1, Helmut O Steinberg, Alain D Baron
1Indiana University School of Medicine, Indianapolis, Indiana, USA.
The Journal of Clinical Investigation
|March 5, 2013
Summary
Insulin resistance impairs glucose uptake and is linked to cardiovascular risks. A key 1996 study revealed its connection to endothelial dysfunction, advancing our understanding of metabolic health.
Area of Science:
- Endocrinology
- Metabolic Syndrome Research
- Cardiovascular Disease Etiology
Background:
- Insulin resistance is a condition where cells fail to respond effectively to insulin, impacting glucose metabolism.
- It is a hallmark of metabolic syndrome and associated with conditions like obesity, type 2 diabetes, and polycystic ovary syndrome.
- Insulin resistance significantly elevates the risk of cardiovascular mortality by 2- to 3-fold.
Purpose of the Study:
- To explore the relationship between insulin resistance and endothelial dysfunction.
- To understand the broader implications of insulin resistance beyond glucose regulation.
- To highlight the significance of early research in advancing the field of insulin action.
Main Methods:
- The abstract does not specify methods, but references a seminal 1996 study by Baron, Steinberg, and colleagues.
- The study likely involved observational or experimental approaches to link insulin resistance markers with endothelial function.
- Further research built upon this foundational observation.
Main Results:
- The 1996 study demonstrated a significant association between insulin resistance and endothelial dysfunction.
- This finding established a novel link between metabolic disturbances and vascular health.
- The research opened new avenues for understanding insulin's role in cardiovascular health.
Conclusions:
- Insulin resistance is a critical factor in metabolic syndrome and cardiovascular disease.
- The link between insulin resistance and endothelial dysfunction is a pivotal discovery.
- Understanding these connections is crucial for developing therapeutic strategies for metabolic and cardiovascular disorders.
Related Concept Videos
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Vascular Resistance
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

